Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 17235042

Phase III randomized trial of conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stem-cell rescue as first-line treatment for patients with poor-prognosis metastatic germ cell tumors.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2007 Jan 20
First author
Motzer RJ

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2007 Jan 20;25(3):239-40. doi: 10.1200/JCO.2006.07.6380.
    note
    Source null
    related pmid
    17235039
    relationship
    Comment in

Authors and identifiers

  1. name
    Motzer RJ
    type
    Author
  2. name
    Nichols CJ
    type
    Author
  3. name
    Margolin KA
    type
    Author
  4. name
    Bacik J
    type
    Author
  5. name
    Richardson PG
    type
    Author
  6. name
    Vogelzang NJ
    type
    Author
  7. name
    Bajorin DF
    type
    Author
  8. name
    Lara PN Jr
    type
    Author
  9. name
    Einhorn L
    type
    Author
  10. name
    Mazumdar M
    type
    Author
  11. name
    Bosl GJ
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Motzer RJ
    type
    Author
  2. name
    Nichols CJ
    type
    Author
  3. name
    Margolin KA
    type
    Author
  4. name
    Bacik J
    type
    Author
  5. name
    Richardson PG
    type
    Author
  6. name
    Vogelzang NJ
    type
    Author
  7. name
    Bajorin DF
    type
    Author
  8. name
    Lara PN Jr
    type
    Author
  9. name
    Einhorn L
    type
    Author
  10. name
    Mazumdar M
    type
    Author
  11. name
    Bosl GJ
    type
    Author
bibliography ids
  1. nci-bib-4fd5343136312d6556bd41cf
book metadata
content sha256
e548464b3d462f1fba32a7e776da3c6cda20bc5add371fa86021a1888a53e188
document type
citation
dois
  1. 10.1200/JCO.2005.05.4528
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:17235042
immutable id
pubmed:17235042@e548464b3d462f1fba32a7e776da3c6cda20bc5add371fa86021a1888a53e188
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
3
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
247-56
volume
25
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2007 Jan 20;25(3):239-40. doi: 10.1200/JCO.2006.07.6380.
    note
    Source null
    related pmid
    17235039
    relationship
    Comment in
outcomes validated
false
pmid
17235042
provenance
batch id
e687ecc838c318f9ec65
provider
NCBI PubMed ESummary
record sha256
5cfecc46b915a5571bd693fbd06a429fbd8158410f9a70fd653a0060f768b803
response sha256
57c28819ed5384f58bd55b57a106357c87d58ddac21f26fe526ca7520d9f61c6
retrieved at
2026-09-09T23:46:11.674833+00:00
publication date
display
2007 Jan 20
precision
day
year
2007
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, N.I.H., Extramural
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/17235042/
title
Phase III randomized trial of conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stem-cell rescue as first-line treatment for patients with poor-prognosis metastatic germ cell tumors.

Preserved source evidence · Not medical advice